Chushu Li
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 2
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 2
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
- Co-authors
- Jie Xu (13 shared papers)Han Yao (12 shared papers)Huanbin Wang (10 shared papers)Jing‐Yuan Fang (10 shared papers)Hubing Shi (4 shared papers)Lunxi Liang (4 shared papers)Lan Jiang (3 shared papers)Yao Zhang (3 shared papers)
- Journals
- Oncogene (2 papers)Nature Biomedical Engineering (1 paper)Advances in experimental medicine and biology (1 paper)Frontiers in Immunology (1 paper)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Chushu Li
14 papers receiving 1.2k citations
Chushu Li's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 710
- Immunology 490
- Cancer Research 186
- Physiology 45
- Molecular Biology 484
Countries citing papers authored by Chushu Li
This map shows the geographic impact of Chushu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chushu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chushu Li more than expected).
Fields of papers citing papers by Chushu Li
This network shows the impact of papers produced by Chushu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chushu Li. The network helps show where Chushu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chushu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours Hit paper breakdown → | 2019 | 403 |
| 2 | 2018 | 249 | |
| 3 | 2018 | 167 | |
| 4 | 2018 | 115 | |
| 5 | 2017 | 78 | |
| 6 | 2017 | 61 | |
| 7 | 2020 | 50 | |
| 8 | 2020 | 34 | |
| 9 | 2017 | 26 | |
| 10 | 2021 | 23 | |
| 11 | 2020 | 12 | |
| 12 | 2018 | 11 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 1 | |
| 15 | 2021 | 0 |
About Chushu Li
Chushu Li is a scholar working on Oncology, Immunology, Molecular Biology, Cell Biology and Pathology and Forensic Medicine, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Peptidase Inhibition and Analysis (3 papers), Immune Cell Function and Interaction (2 papers), Cancer-related Molecular Pathways (2 papers), CAR-T cell therapy research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (710 citations), Immunology (490 citations), Cancer Research (186 citations), Physiology (45 citations) and Molecular Biology (484 citations). Chushu Li has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Jie Xu, Han Yao, Huanbin Wang, Jing‐Yuan Fang, Hubing Shi, Lunxi Liang, Lan Jiang, Yao Zhang, Haojie Lu and Jean‐Philippe Brosseau. Their work appears in journals such as Oncogene, Nature Biomedical Engineering, Advances in experimental medicine and biology, Frontiers in Immunology and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.